Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 19Neoplasms 11Polycystic Ovary Syndrome 9Neoplasm Metastasis 4Multiple Myeloma 4Melanoma 4Vomiting 3Prostatic Neoplasms 3Leukemia, Myeloid, Acute 3Leiomyoma 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Triple Negative Breast Neoplasms 2Solid Tumors 2Skin Neoplasms 2Sarcoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peripheral Nervous System Diseases 2Ovarian Neoplasms 2Obesity 2Nausea 2Myofibroma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, B-Cell 2Leukemia 2Insulin Resistance 2Inflammation 2Infertility, Female 2

Interventions

Alpelisib 3Sirolimus 2mirdametinib 1Tablets 1Surgical Procedures, Operative 1Sildenafil Citrate 1Sclerotherapy 1Risk Factors 1Picibanil 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphangioma × Tablets × Clear all
NCT06160739 2023-12-15

Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations

Sohag University

Unknown
10 enrolled

Lymphangioma, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡